Lexicon Pharmaceuticals, Inc.
LXRX
$1.12
-$0.03-2.61%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.25M | -25.30M | -33.77M | -64.81M | -53.43M |
| Total Depreciation and Amortization | 176.00K | 176.00K | 125.00K | 126.00K | 139.00K |
| Total Amortization of Deferred Charges | 402.00K | 401.00K | 401.00K | 402.00K | 525.00K |
| Total Other Non-Cash Items | 1.96M | 177.00K | -19.00K | 974.00K | -25.00K |
| Change in Net Operating Assets | 11.20M | -19.24M | 11.77M | 9.69M | 4.25M |
| Cash from Operations | 16.99M | -43.78M | -21.49M | -53.62M | -48.54M |
| Capital Expenditure | -- | -- | -474.00K | -307.00K | -250.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.48M | 40.58M | 54.17M | 53.78M | -12.07M |
| Cash from Investing | 15.48M | 40.58M | 53.70M | 53.47M | -12.32M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -45.00M | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 1.00K |
| Repurchase of Common Stock | 0.00 | -572.00K | -25.00K | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -78.00K | -10.00K | -15.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1.00K | -906.00K | 0.00 |
| Cash from Financing | -45.00M | -572.00K | -104.00K | -916.00K | -14.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.52M | -3.77M | 32.11M | -1.07M | -60.88M |